This study is in progress, not accepting new patients
Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease
Summary
- Eligibility
- for people ages 40 years and up (full criteria)
- Location
- at Irvine, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Novartis Pharmaceuticals
- ID
- NCT05030428
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- About 17004 people participating
- Last Updated